Published in Medical Letter on the CDC and FDA, October 20th, 1997
The report was presented by researcher Susan Ashkar and colleagues at the 1997 Infectious Disease Society of America Annual Meeting, held September 13-16 in San Francisco, California.
Mycobacterium tuberculosis with rifampin monoresistance has been uncommon, but now is being seen with increasing frequency.
To elucidate the characteristics of monoresistant TB presentation, Ashkar et al....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.